BriaCell (BCTX) news
Recent news
Briacell Therapeutics Corp - announces manufacturing arrangement with Fujifilm Biotechnologies California for Bria-IMT
AInvest Wire · Jul 15, 2026Briacell Therapeutics Corp - arrangement provides manufacturing capacity for Phase 3 study and commercial scalability
AInvest Wire · Jul 15, 2026Briacell Therapeutics Corp - enters MOU with Unneedle for microneedle administration of Bria-IMT
BriaCell Therapeutics Corp. (TSX-V:BCT) has entered into a memorandum of understanding (MOU) with Unneedle, a company specializing in microneedle drug delivery technology, to explore the potential use of microneedle administration for Bria-IMT™, the company’s lead immunotherapy candidate for…
AInvest Wire · Jun 25, 2026Briacell Therapeutics announces closing of offering
AInvest Wire · Jun 2, 2026BriaCell falls on $5M stock offering
BriaCell falls on $5M stock offering BriaCell Therapeutics Corp. (BCT), a clinical-stage biotechnology firm specializing in targeted immunotherapies for advanced breast cancer, announced the pricing of a public offering on February 23, 2021. The offering aims to raise approximately $25 million…
AInvest Wire · May 15, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.